Trial
NCT04776850
Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
M.D. Anderson Cancer Center
Collaborators
—
Condition
Beta Thalassemia Major
Intervention
Bortezomib
Why stopped
Competing protocol opened in Adult SCT that will include pediatric patients and is now multi-center. No patients enrolled on study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-10-24